Little Bite, Big Disease: Recognizing and Managing Tickborne Illnesses

Date:Tuesday, May 24, 2016

Presenter(s)

Naomi Drexler, MPH 
Epidemiologist
Rickettsial Zoonoses Branch
Division of Vector-Borne Diseases
Centers for Disease Control and Prevention

Christina Nelson MD, MPH
Medical Epidemiologist
Bacterial Diseases Branch
Division of Vector-Borne Diseases
Centers for Disease Control and Prevention

Elizabeth Schiffman, MPH, MA
Senior Epidemiologist
Minnesota Department of Health

Overview

Ticks transmit over a dozen infectious pathogens in the United States, including Lyme disease and Rocky Mountain spotted fever. Recent discoveries of emerging pathogens such as Borrelia mayonii and Ehrlichia muris add to the complexity of properly diagnosing and treating tickborne diseases. As we approach summer and people become more active in the outdoors, reports of tick bites and tickborne diseases are expected to increase. Clinicians can help prevent complications associated with tickborne diseases with early recognition and prompt treatment. During this COCA Call, clinicians will learn about the treatment, management, and prevention of tickborne diseases in the U.S., with an emphasis on Lyme disease, Rocky Mountain spotted fever and newly emerging tickborne diseases.

Objectives

  • Review the geographic distribution of Lyme disease, Southern tick-associated rash illness (STARI), Rocky Mountain spotted fever, ehrlichiosis, anaplasmosis, and other emerging tickborne diseases.
  • Define the symptoms of Lyme disease, STARI, Rocky Mountain spotted fever, ehrlichiosis, anaplasmosis, and emerging tickborne diseases.
  • Identify the serologic tests used to diagnose Lyme disease, Rocky Mountain spotted fever, ehrlichiosis, anaplasmosis, and emerging tickborne diseases.
  • Describe the appropriate use of antibiotics in treating Lyme disease, STARI, Rocky Mountain spotted fever, ehrlichiosis, anaplasmosis, and emerging tickborne diseases.

Call Materials

Additional Resources

Call Format

  • Audio conference call on 5/24/16: 2:00 – 3:00 PM EST
  • Web-on-demand training after 3:00 PM EST on 5/24/16
  • Materials: PowerPoint slide set

Accreditation Statements

“WC2286” for attendees who participate in the live call (must be completed by June 23, 2016)
“WD2286” for attendees who participate in the online presentation (must be completed by June 23, 2018)

  • Physicians
  • Nurses
  • Pharmacists
  • Veterinarians
  • Physician Assistants
  • Health Educators
  • Other Clinicians

  • Contact Information:coca@cdc.gov
  • Support/Funding:Centers for Disease Control and Prevention, Emergency Risk Communications Branch
  • Method of Participation:You may participate in the educational activity by viewing the program information above.
  • Fees:COCA continuing education credits are free.

Accreditation Statements

CME:The Centers for Disease Control and Prevention is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians.

The Centers for Disease Control and Prevention designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

CNE:The Centers for Disease Control and Prevention is accredited as a provider of Continuing Nursing Education by the American Nurses Credentialing Center’s Commission on Accreditation.

This activity provides 1.0 contact hour.

IACET CEU:The Centers for Disease Control and Prevention is authorized by IACET to offer 1.0 CEU’s for this program.

CECH:Sponsored by the Centers for Disease Control and Prevention, a designated provider of continuing education contact hours (CECH) in health education by the National Commission for Health Education Credentialing, Inc. This program is designed for Certified Health Education Specialists (CHES) and/or Master Certified Health Education Specialists (MCHES) to receive up to 1.0 total Category I continuing education contact hours. Maximum advanced level continuing education contact hours available are 0. CDC provider number 98614.

Image of acpe logo.CPE:The Centers for Disease Control and Prevention is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This program is a designated event for pharmacists to receive 0.1 CEUs in pharmacy education. The Universal Activity Number is 0387-0000-16-078-L04-P and enduring 0387-0000-16-078-H04-P course category.

Course Category: This activity has been designated as knowledge-based.

Once credit is claimed, an unofficial statement of credit is immediately available on TCEOnline. Official credit will be uploaded within 60 days on the NABP/CPE Monitor.

AAVSB/RACE:This program was reviewed and approved by the AAVSB RACE program for 1.0 hours of continuing education in the jurisdictions which recognize AAVSB RACE approval. Please contact the AAVSB RACE Program at race@aavsb.org if you have any comments/concerns regarding this program’s validity or relevancy to the veterinary profession.

CPH: The Centers for Disease Control and Prevention is a pre-approved provider of Certified in Public Health (CPH) recertification credits and is authorized to offer 1 CPH recertification credit for this program.

CDC is an approved provider of CPH Recertification Credits by the National Board of Public Health Examiners. Effective October 1, 2013, the National Board of Public Health Examiners (NBPHE) accepts continuing education units (CEU) for CPH recertification credits from CDC. Please select CEU as your choice for continuing education when registering for a course on TCEOnline. Learners seeking CPH should use the guidelines provided by the NBPHE for calculating recertification credits. For assistance please contact NBPHE at http://www.NBPHE.orgExternal.

There is no cost for this program.

DISCLOSURE: In compliance with continuing education requirements, CDC, our planners, our presenters, and their spouses/partners wish to disclose they have no financial interests or other relationships with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters. Planners have reviewed content to ensure there is no bias.
The presentation will not include any discussion of the unlabeled use of a product or a product under investigational use.
CDC does not accept commercial support.

Page last reviewed: March 1, 2016 (archived document)